Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNA, 7SL, cytoplasmic 767, pseudogene (RN7SL767P) is classified as a pseudogene related to the 7SL RNA, a non-coding RNA component of the signal recognition particle (SRP). The authentic 7SL RNA plays a central role in targeting secretory proteins to the endoplasmic reticulum, but RN7SL767P is a truncated, inactive copy resulting from the integration of sequences derived from 7SL RNA back into the genome via reverse transcription. Human genome contains hundreds of similar 7SL RNA-related pseudogenes and Alu elements; only a few encode functional 7SL RNA, while the rest, like RN7SL767P, are not known to be transcribed or to produce any functional RNA or protein product. There is no evidence that this specific pseudogene is involved in disease, functional biological regulation, or that it interacts with drugs. Its presence mainly reflects genomic evolutionary history and the widespread retrotransposition events associated with the 7SL RNA family.
Not applicable
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, 7SL, cytoplasmic 767, pseudogene (RN7SL767P).